跳至主要内容
临床试验/JPRN-UMIN000044917
JPRN-UMIN000044917已完成未知

Study to evaluate the effect of continuous intake of test food on the decrease of focusing accommodation attributed to eye strain -Crossover study- - Study to evaluate the effect of continuous intake of test food on the decrease of focusing accommodation attributed to eye strain

IMEQRD Co., Ltd0 个研究点目标入组 30 人开始时间: 2021年7月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25years-old 至 40years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Those who are attending a hospital or receiving treatment of medicines or Chinese medicines due to disease. 2. Those who had LASIK surgery in past. 3. Those who are receiving nutrition therapy or physical therapy under doctor's supervision. 4. Those who have a current or past medical history of severe diseases or organic eye disease. 5. Those who have entropion or trichiasis 6. Those whose measured value of astigmatometry is more than 1.25 D. 7. Those who wear eyelash extensions. 8. Those who do not have sleep enough. 9. Those who are likely to onset allergic conjunctivitis (seasonal or year-round) during this trial. 10. Those who currently and regularly use OTC medicines or quasi drugs (including eye drops), food for specified health uses, foods with functional claims, dietary supplements, or supplements. 11. Those who take yogurt or lactic acid bacteria drinks daily for health (However, except those who can quit taking them during this trial after obtaining consent). 12. Those who have current or history of drug allergies or food allergies. 13. Those who drink a lot of alcohol (60g/day alcohol conversion). 14. Those who have habit of smoking. 15. Those who are likely to change lifestyle (meal, sleep, motional activity), such as long trip, working night shift, and not able to keep certain lifestyle. 16. Those who are pregnant or lactating, or willing to be pregnant during the trial. 17. Those who had been participating in another clinical trial within one month before obtaining consent to the trial, or planning to participate during another clinical trial. 18. Those who were determined by the principal investigator to be unsuitable for this clinical test.

研究者

发起方
IMEQRD Co., Ltd

相似试验